Dose Finding Study of L19TNF and Doxorubicin in Patients With STS

NCT04032964 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: L19TNF
DRUG: DOXORUBICIN

Sponsor

Philogen S.p.A.